Ethema Health Corporation: 10-Q filed 2024-11-14

Name: Ethema Health Corporation: 10-Q filed 2024-11-14
Creator: Ethema Health Corporation

What Ethema Health Corporation reported in its quarterly report filed 2024-11-14 (fiscal Q3 2024): 40 published measures, 109 facts as tagged in accession 0001903596-24-000678.

This filing

Form: 10-Q (quarterly report)
Filed: 2024-11-14
Fiscal period: fiscal Q3 2024
Accession: 0001903596-24-000678 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All Ethema Health Corporation filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

Period	Value	Unit	Days
At 2024-09-30	12,316,463	USD
At 2023-12-31	11,519,176	USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

Period	Value	Unit	Days
At 2024-09-30	19,450,935	USD
At 2023-12-31	17,719,456	USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

Period	Value	Unit
At 2024-09-30	-7,134,472	USD
At 2024-06-30	-8,139,758	USD
At 2024-03-31	-6,574,483	USD
At 2023-12-31	-6,200,280	USD
At 2023-09-30	-5,507,030	USD
At 2023-06-30	-7,886,506	USD
At 2023-03-31	-9,433,183	USD
At 2022-12-31	-9,232,543	USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

Period	Value	Unit	Days
At 2024-09-30	60,862	USD
At 2023-12-31	68,573	USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

Period	Value	Unit	Days
2024-01-01 to 2024-09-30	-1,840,192	USD	274
2023-01-01 to 2023-09-30	1,699,665	USD	273

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

Period	Value	Unit	Days
2024-01-01 to 2024-09-30	-377,954	USD	274
2023-01-01 to 2023-09-30	-575,790	USD	273

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

Period	Value	Unit	Days
2024-01-01 to 2024-09-30	85,522	USD	274
2023-01-01 to 2023-09-30	5,244,011	USD	273

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

Period	Value	Unit	Days
2024-07-01 to 2024-09-30	1,760,000	USD	92
2024-01-01 to 2024-09-30	4,550,200	USD	274
2023-07-01 to 2023-09-30	1,353,899	USD	92
2023-01-01 to 2023-09-30	4,219,904	USD	273

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

Period	Value	Unit	Days
2024-01-01 to 2024-09-30	1,415,265	USD	274
2023-01-01 to 2023-09-30	-2,099,676	USD	273

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

Period	Value	Unit	Days
2024-01-01 to 2024-09-30	-1,033,915	USD	274
2023-01-01 to 2023-09-30	2,475,437	USD	273

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

Period	Value	Unit	Days
At 2024-09-30	-44,093,727	USD
At 2023-12-31	-42,355,377	USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

Period	Value	Unit	Days
2024-07-01 to 2024-09-30	7,207,314,674	shares	92
2024-01-01 to 2024-09-30	4,896,937,017	shares	274
2023-07-01 to 2023-09-30	3,729,053,805	shares	92
2023-01-01 to 2023-09-30	3,729,053,805	shares	273

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

Period	Value	Unit	Days
2024-07-01 to 2024-09-30	7,207,314,674	shares	92
2024-01-01 to 2024-09-30	4,896,937,017	shares	274
2023-07-01 to 2023-09-30	3,931,379,775	shares	92
2023-01-01 to 2023-09-30	3,931,379,775	shares	273

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

Period	Unit	Days
2024-07-01 to 2024-09-30	USD/shares	92
2024-01-01 to 2024-09-30	USD/shares	274
2023-07-01 to 2023-09-30	USD/shares	92
2023-01-01 to 2023-09-30	USD/shares	273

Diluted earnings per share

Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.

Period	Unit	Days
2024-07-01 to 2024-09-30	USD/shares	92
2024-01-01 to 2024-09-30	USD/shares	274
2023-07-01 to 2023-09-30	USD/shares	92
2023-01-01 to 2023-09-30	USD/shares	273

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

Period	Value	Unit	Days
2023-07-01 to 2023-09-30	-15,532	USD	92
2023-01-01 to 2023-09-30	-221,107	USD	273

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

Period	Value	Unit	Days
At 2024-09-30	756,395	USD
At 2023-12-31	508,401	USD

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

Period	Value	Unit	Days
2024-07-01 to 2024-09-30	-723,708	USD	92
2024-01-01 to 2024-09-30	-1,230,293	USD	274
2023-07-01 to 2023-09-30	33,528	USD	92
2023-01-01 to 2023-09-30	140,700	USD	273

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

Period	Value	Unit	Days
At 2024-09-30	472,424	USD
At 2023-12-31	403,100	USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

Period	Value	Unit	Days
At 2024-09-30	7,541,298	USD
At 2023-12-31	8,298,904	USD

Net finite-lived intangible assets

Finite-lived intangible assets after amortization. This excludes goodwill and should not be combined with indefinite-lived intangible assets without checking scope.

Period	Value	Unit	Days
At 2024-09-30	626,467	USD
At 2023-12-31	894,952	USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

Period	Value	Unit	Days
At 2024-09-30	381,307	USD
At 2023-12-31	313,338	USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

Period	Value	Unit	Days
2024-07-01 to 2024-09-30	2,483,708	USD	92
2024-01-01 to 2024-09-30	5,780,493	USD	274
2023-07-01 to 2023-09-30	1,320,371	USD	92
2023-01-01 to 2023-09-30	4,079,204	USD	273

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

Period	Value	Unit	Days
At 2024-09-30	7,729,053,805	shares
At 2023-12-31	3,729,053,805	shares

Cash including restricted cash

Cash, cash equivalents and restricted cash as reported in the cash flow reconciliation. Restricted amounts are not freely available, so this is not the same as unrestricted cash.

Period	Value	Unit
At 2024-09-30	60,862	USD
At 2023-12-31	68,573	USD
At 2023-09-30	11,728	USD
At 2022-12-31	140,757	USD

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

Period	Value	Unit	Days
At 2024-09-30	24,986,083	USD
At 2023-12-31	26,187,925	USD

Total equity including noncontrolling interests

Equity including the portion attributable to noncontrolling interests. It is larger than or equal to parent stockholders equity and is not market capitalization.

Period	Value	Unit	Days
At 2024-09-30	-7,134,472	USD
At 2023-12-31	-6,200,280	USD

Operating lease right-of-use asset

Carrying amount of the right to use leased assets under operating leases. It reflects discounted remaining payments, not the value of the underlying property.

Period	Value	Unit	Days
At 2024-09-30	9,988,784	USD
At 2023-12-31	9,323,723	USD

Operating lease liability

Present value of remaining operating lease payments. Discount-rate choices and lease terms affect the amount; it is not the sum of undiscounted future rent.

Period	Value	Unit	Days
At 2024-09-30	10,261,355	USD

Gross property, plant and equipment

Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.

Period	Value	Unit	Days
At 2024-09-30	1,000,670	USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

Period	Value	Unit	Days
At 2024-09-30	244,275	USD

Pre-tax income or loss from continuing operations

Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.

Period	Value	Unit	Days
2024-07-01 to 2024-09-30	-1,000,714	USD	92
2024-01-01 to 2024-09-30	-1,840,192	USD	274
2023-07-01 to 2023-09-30	2,092,005	USD	92
2023-01-01 to 2023-09-30	1,478,558	USD	273

Comprehensive income or loss

Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.

Period	Value	Unit	Days
2024-07-01 to 2024-09-30	-1,000,714	USD	92
2024-01-01 to 2024-09-30	-1,738,350	USD	274
2023-07-01 to 2023-09-30	2,076,479	USD	92
2023-01-01 to 2023-09-30	1,529,599	USD	273

Net income available to common stockholders

Net income after preferred dividends and similar adjustments, the numerator for basic earnings per share. It can be lower than reported net income.

Period	Value	Unit	Days
2024-07-01 to 2024-09-30	-1,000,714	USD	92
2024-01-01 to 2024-09-30	-1,738,350	USD	274
2023-07-01 to 2023-09-30	2,076,479	USD	92
2023-01-01 to 2023-09-30	1,524,534	USD	273

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

Period	Value	Unit	Days
2024-07-01 to 2024-09-30	417,888	USD	92
2024-01-01 to 2024-09-30	1,055,663	USD	274
2023-07-01 to 2023-09-30	249,283	USD	92
2023-01-01 to 2023-09-30	755,685	USD	273

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

Period	Value	Unit	Days
2024-07-01 to 2024-09-30	33,226	USD	92
2024-01-01 to 2024-09-30	77,528	USD	274
2023-07-01 to 2023-09-30	20,690	USD	92
2023-01-01 to 2023-09-30	119,774	USD	273

Depreciation, depletion and amortization

Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.

Period	Value	Unit	Days
2024-01-01 to 2024-09-30	346,013	USD	274
2023-01-01 to 2023-09-30	388,259	USD	273

Interest paid, net

Cash interest paid during the period, net of amounts capitalized where the filer reports it that way. It differs from interest expense recognized.

Period	Value	Unit	Days
2024-01-01 to 2024-09-30	248,079	USD	274
2023-01-01 to 2023-09-30	334,735	USD	273

Operating lease payments

Cash paid for operating lease liabilities during the period. It differs from lease expense recognized and excludes variable payments in some presentations.

Period	Value	Unit	Days
2024-01-01 to 2024-09-30	738,760	USD	274
2023-01-01 to 2023-09-30	446,189	USD	273

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

Period	Value	Unit	Days
2024-01-01 to 2024-09-30	-62,671	USD	274
2023-01-01 to 2023-09-30	289,697	USD	273

Inspect the source

Entity: Ethema Health Corporation / CIK 0000792935
Captured: 2026-09-21T17:17:01.527Z
SEC response SHA-256: a4f8fd956c34e77db45dcdd54cc03aee5ac808fb7b9e32559ac9d8a78af1e44e

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python

import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0000792935.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))